
Zepbound & Mounjaro Savings Card 2026: How to Get $25/Month Tirzepatide
The Zepbound savings card cuts your copay to $25/month if your insurance covers it. Here's how to activate it, eligibility rules, and what to do if you don't qualify.
11 articles tagged #tirzepatide.

The Zepbound savings card cuts your copay to $25/month if your insurance covers it. Here's how to activate it, eligibility rules, and what to do if you don't qualify.

Compounded tirzepatide costs $149–$300/mo vs $1,086/mo for brand-name Zepbound. Here's what it is, whether it's legal, how safe it is, and the best providers.

Tirzepatide costs $149–$425/mo through telehealth vs $1,086/mo list price for Zepbound. Here's every pricing option with and without insurance.

A practical guide to the most common GLP-1 side effects — nausea, GI issues, hair loss, and more — with evidence-based strategies to manage them and red flags that mean you should call your doctor.

Certain foods can make GLP-1 side effects dramatically worse. Learn which foods to avoid on Ozempic, Wegovy, and Zepbound — plus what to eat instead for better tolerance and results.

Tirzepatide produces 20.2% weight loss vs semaglutide's 13.7% in head-to-head trials, but costs $50–$150/mo more. Full comparison of efficacy, side effects, cost, and which one to choose in 2026.

The two most prescribed GLP-1 weight loss drugs go head to head — clinical results, pricing, side effects, insurance, and which one is right for you.

Beyond Wegovy and Zepbound, a new generation of obesity drugs is racing toward FDA approval. CagriSema, MariTide (monthly injection), survodutide, and more — here's every drug in the pipeline with clinical data.

Retatrutide achieved 28.7% weight loss in Phase 3 trials — nearly double semaglutide. Here's everything known about Eli Lilly's next-generation triple-agonist, from clinical data to expected approval timeline.

Starting a GLP-1? Here's a realistic week-by-week breakdown of what happens — from the initial consultation through your first dose escalation.

Everything you need to know about GLP-1 receptor agonists — how they work, what the clinical trials show, side effects, eligibility, and how to choose a provider.